A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents

Julio Cárdenas-Rodríguez, Christine M. Howison, Terry O Matsunaga, Mark "Marty" Pagel

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Dynamic Contrast Enhancement (DCE) MRI has been used to measure the kinetic transport constant, Ktrans, which is used to assess tumor angiogenesis and the effects of anti-angiogenic therapies. Standard DCE MRI methods must measure the pharmacokinetics of a contrast agent in the blood stream, known as the Arterial Input Function (AIF), which is then used as a reference for the pharmacokinetics of the agent in tumor tissue. However, the AIF is difficult to measure in pre-clinical tumor models and in patients. Moreover the AIF is dependent on the Fahraeus effect that causes a highly variable hematocrit (Hct) in tumor microvasculature, leading to erroneous estimates of Ktrans. To overcome these problems, we have developed the Reference Agent Model (RAM) for DCE MRI analyses, which determines the relative Ktrans of two contrast agents that are simultaneously co-injected and detected in the same tissue during a single DCE-MRI session. The RAM obviates the need to monitor the AIF because one contrast agent effectively serves as an internal reference in the tumor tissue for the other agent, and it also eliminates the systematic errors in the estimated Ktrans caused by assuming an erroneous Hct. Simulations demonstrated that the RAM can accurately and precisely estimate the relative Ktrans (RKtrans) of two agents. To experimentally evaluate the utility of RAM for analyzing DCE MRI results, we optimized a previously reported multiecho 19F MRI method to detect two perfluorinated contrast agents that were co-injected during a single in vivo study and selectively detected in the same tumor location. The results demonstrated that RAM determined RKtrans with excellent accuracy and precision.

Original languageEnglish (US)
Pages (from-to)900-910
Number of pages11
JournalMagnetic Resonance Imaging
Volume31
Issue number6
DOIs
StatePublished - Jul 2013

Fingerprint

Capillary Permeability
Magnetic resonance imaging
Contrast Media
Tumors
Neoplasms
Pharmacokinetics
Hematocrit
Tissue
Angiogenesis Inducing Agents
Microvessels
Systematic errors
Blood
Kinetics

Keywords

  • F MRI
  • Dynamic contrast enhanced MRI
  • Linear models
  • Perfluorocarbons
  • Permeability
  • Pharmacokinetics
  • Reference agent model

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging
  • Biomedical Engineering

Cite this

A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents. / Cárdenas-Rodríguez, Julio; Howison, Christine M.; Matsunaga, Terry O; Pagel, Mark "Marty".

In: Magnetic Resonance Imaging, Vol. 31, No. 6, 07.2013, p. 900-910.

Research output: Contribution to journalArticle

@article{b2ba4018d202481ab814de53fdb80bf6,
title = "A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents",
abstract = "Dynamic Contrast Enhancement (DCE) MRI has been used to measure the kinetic transport constant, Ktrans, which is used to assess tumor angiogenesis and the effects of anti-angiogenic therapies. Standard DCE MRI methods must measure the pharmacokinetics of a contrast agent in the blood stream, known as the Arterial Input Function (AIF), which is then used as a reference for the pharmacokinetics of the agent in tumor tissue. However, the AIF is difficult to measure in pre-clinical tumor models and in patients. Moreover the AIF is dependent on the Fahraeus effect that causes a highly variable hematocrit (Hct) in tumor microvasculature, leading to erroneous estimates of Ktrans. To overcome these problems, we have developed the Reference Agent Model (RAM) for DCE MRI analyses, which determines the relative Ktrans of two contrast agents that are simultaneously co-injected and detected in the same tissue during a single DCE-MRI session. The RAM obviates the need to monitor the AIF because one contrast agent effectively serves as an internal reference in the tumor tissue for the other agent, and it also eliminates the systematic errors in the estimated Ktrans caused by assuming an erroneous Hct. Simulations demonstrated that the RAM can accurately and precisely estimate the relative Ktrans (RKtrans) of two agents. To experimentally evaluate the utility of RAM for analyzing DCE MRI results, we optimized a previously reported multiecho 19F MRI method to detect two perfluorinated contrast agents that were co-injected during a single in vivo study and selectively detected in the same tumor location. The results demonstrated that RAM determined RKtrans with excellent accuracy and precision.",
keywords = "F MRI, Dynamic contrast enhanced MRI, Linear models, Perfluorocarbons, Permeability, Pharmacokinetics, Reference agent model",
author = "Julio C{\'a}rdenas-Rodr{\'i}guez and Howison, {Christine M.} and Matsunaga, {Terry O} and Pagel, {Mark {"}Marty{"}}",
year = "2013",
month = "7",
doi = "10.1016/j.mri.2012.12.002",
language = "English (US)",
volume = "31",
pages = "900--910",
journal = "Magnetic Resonance Imaging",
issn = "0730-725X",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents

AU - Cárdenas-Rodríguez, Julio

AU - Howison, Christine M.

AU - Matsunaga, Terry O

AU - Pagel, Mark "Marty"

PY - 2013/7

Y1 - 2013/7

N2 - Dynamic Contrast Enhancement (DCE) MRI has been used to measure the kinetic transport constant, Ktrans, which is used to assess tumor angiogenesis and the effects of anti-angiogenic therapies. Standard DCE MRI methods must measure the pharmacokinetics of a contrast agent in the blood stream, known as the Arterial Input Function (AIF), which is then used as a reference for the pharmacokinetics of the agent in tumor tissue. However, the AIF is difficult to measure in pre-clinical tumor models and in patients. Moreover the AIF is dependent on the Fahraeus effect that causes a highly variable hematocrit (Hct) in tumor microvasculature, leading to erroneous estimates of Ktrans. To overcome these problems, we have developed the Reference Agent Model (RAM) for DCE MRI analyses, which determines the relative Ktrans of two contrast agents that are simultaneously co-injected and detected in the same tissue during a single DCE-MRI session. The RAM obviates the need to monitor the AIF because one contrast agent effectively serves as an internal reference in the tumor tissue for the other agent, and it also eliminates the systematic errors in the estimated Ktrans caused by assuming an erroneous Hct. Simulations demonstrated that the RAM can accurately and precisely estimate the relative Ktrans (RKtrans) of two agents. To experimentally evaluate the utility of RAM for analyzing DCE MRI results, we optimized a previously reported multiecho 19F MRI method to detect two perfluorinated contrast agents that were co-injected during a single in vivo study and selectively detected in the same tumor location. The results demonstrated that RAM determined RKtrans with excellent accuracy and precision.

AB - Dynamic Contrast Enhancement (DCE) MRI has been used to measure the kinetic transport constant, Ktrans, which is used to assess tumor angiogenesis and the effects of anti-angiogenic therapies. Standard DCE MRI methods must measure the pharmacokinetics of a contrast agent in the blood stream, known as the Arterial Input Function (AIF), which is then used as a reference for the pharmacokinetics of the agent in tumor tissue. However, the AIF is difficult to measure in pre-clinical tumor models and in patients. Moreover the AIF is dependent on the Fahraeus effect that causes a highly variable hematocrit (Hct) in tumor microvasculature, leading to erroneous estimates of Ktrans. To overcome these problems, we have developed the Reference Agent Model (RAM) for DCE MRI analyses, which determines the relative Ktrans of two contrast agents that are simultaneously co-injected and detected in the same tissue during a single DCE-MRI session. The RAM obviates the need to monitor the AIF because one contrast agent effectively serves as an internal reference in the tumor tissue for the other agent, and it also eliminates the systematic errors in the estimated Ktrans caused by assuming an erroneous Hct. Simulations demonstrated that the RAM can accurately and precisely estimate the relative Ktrans (RKtrans) of two agents. To experimentally evaluate the utility of RAM for analyzing DCE MRI results, we optimized a previously reported multiecho 19F MRI method to detect two perfluorinated contrast agents that were co-injected during a single in vivo study and selectively detected in the same tumor location. The results demonstrated that RAM determined RKtrans with excellent accuracy and precision.

KW - F MRI

KW - Dynamic contrast enhanced MRI

KW - Linear models

KW - Perfluorocarbons

KW - Permeability

KW - Pharmacokinetics

KW - Reference agent model

UR - http://www.scopus.com/inward/record.url?scp=84878667457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878667457&partnerID=8YFLogxK

U2 - 10.1016/j.mri.2012.12.002

DO - 10.1016/j.mri.2012.12.002

M3 - Article

C2 - 23583323

AN - SCOPUS:84878667457

VL - 31

SP - 900

EP - 910

JO - Magnetic Resonance Imaging

JF - Magnetic Resonance Imaging

SN - 0730-725X

IS - 6

ER -